Navigation Links
Evolution offers clues to leading cause of death during childbirth

Unusual features of the human placenta may be the underlying cause of postpartum hemorrhage, the leading cause of maternal deaths during childbirth, according to evolutionary research at the University of Illinois at Chicago.

Defined as the loss of more than a pint of blood during or just after vaginal delivery, postpartum hemorrhage accounts for nearly 35 percent, or 125,000, of the 358,000 worldwide annual maternal deaths during childbirth.

Despite its prevalence, the causes of postpartum hemorrhage are unknown, says Julienne Rutherford, assistant professor of oral biology at UIC, who along with Elizabeth Abrams, assistant professor of anthropology, co-authored a theoretical synthesis published in the journal American Anthropologist. While common in humans, postpartum hemorrhage is rare in other mammals, including nonhuman primates.

"Understanding the underlying cause of the increased risk of postpartum hemorrhage in humans is a critical step toward discovering new treatments and eventually preventing it on a global scale," Rutherford said.

Previous studies on postpartum hemorrhage have focused on how it can be treated and on recognizing its associated risk factors, Abrams said. Less has been done to discover its cause.

In humans, the invasiveness of the placenta into the uterine wall and the subsequent takeover of maternal blood vessels appear to be greater than in nonhumans, Rutherford said. This suggests a link between placental invasiveness early in pregnancy and blood loss at delivery, when the placenta separates from the uterine wall.

Research by Abrams and Rutherford suggests that hormones produced by trophoblasts -- cells formed during the first stage of pregnancy that provide nutrients to the embryo and develop into a large part of the placenta, and that guide the interaction with the uterus -- may provide an early predictor of risk.

"Biomarkers of postpartum hemorrhage that could be used early in pregnancy would allow women to make informed decisions about their choice of birthing site and medical care based on their risk," Abrams said. This biomarker hypothesis has not yet been studied.

Many women in poor countries don't give birth in hospitals or clinics, said Abrams, who has conducted research on childbirth in the sub-Saharan countries of Malawi and Tanzania. By the time postpartum bleeding occurs, it may be too late to reach a health center.

In a normal birth, the placenta begins to separate from the uterine wall before delivery. Bleeding at the site is normally stopped by the constriction of blood vessels due to the contraction and retraction of uterine muscles. Hemorrhage can occur weeks after birth, but most deaths occur within four hours of delivery.

There are two major risk factors for postpartum hemorrhage, said Rutherford. The leading factor is uterine contractions that are too weak to stop bleeding. The cause of this is unclear, but it could delay delivery of the placenta -- which is the other known risk factor, she said. The best predictor for any woman is previous postpartum hemorrhage, "which has disturbing implications for women in resource-poor settings," Abrams said.

Understanding how the human placenta differs from that of other primates is a new approach, and according to Abrams and Rutherford, it is one that might help explain the mechanisms underlying risk factors in humans.

Contact: Sam Hostettler
University of Illinois at Chicago

Related biology news :

1. Worm genome offers clues to evolution of parasitism
2. Advance offers revolution in food safety testing
3. Mass extinctions and the evolution of dinosaurs
4. Egalitarian revolution in the Pleistocene?
5. Reproducing early and often is the key to rapid evolution in plants
6. Illuminating biology: An evolutionary perspective
7. Biologists, educators recognize excellence in evolution education
8. Revealing the evolutionary history of threatened sea turtles
9. Details of evolutionary transition from fish to land animals revealed
10. Genetic based human diseases are an ancient evolutionary legacy
11. Wake Forest plays integral role in effort to revolutionize vehicle safety
Post Your Comments:
(Date:11/10/2015)... 10, 2015 About signature ... helps to identify and verify the identity of ... as the secure and accurate method of authentication ... particular individual because each individual,s signature is highly ... when dynamic signature of an individual is compared ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... 2015  Asia-Pacific (APAC) holds the third-largest share ... The trend of outsourcing to low-cost locations is ... volume share for the region in the short ... in the CRO industry will improve. ... ), finds that the market earned revenues ...
(Date:11/24/2015)... 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... New York on Wednesday, December 2 at 9:30 ... president and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim ... provide a corporate overview. --> th Annual Oppenheimer ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... event of the year and one of the premier annual events for pharmaceutical ... ran from 8–11 November 2015, where ISPE hosted the largest number of attendees ...
(Date:11/24/2015)... 24, 2015 --> ... report "Oligonucleotide Synthesis Market by Product & Services (Primer, ... Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic ... the market is expected to reach USD 1,918.6 Million ... a CAGR of 10.1% during the forecast period. ...
Breaking Biology Technology: